Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,357 | 1 | 58.3% |
| Consulting Fee | $840.00 | 1 | 36.1% |
| Food and Beverage | $101.13 | 5 | 4.3% |
| Education | $28.99 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Partner Therapeutics, Inc. | $1,357 | 1 | $0 (2022) |
| Gilead Sciences, Inc. | $863.90 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $50.00 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $28.99 | 1 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $27.23 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.47 | 1 | Gilead Sciences, Inc. ($19.47) |
| 2023 | $844.43 | 2 | Gilead Sciences, Inc. ($844.43) |
| 2022 | $1,357 | 1 | Partner Therapeutics, Inc. ($1,357) |
| 2018 | $78.99 | 2 | Novartis Pharmaceuticals Corporation ($50.00) |
| 2017 | $27.23 | 2 | Merck Sharp & Dohme Corporation ($27.23) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.47 | General |
| 12/19/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $840.00 | General |
| Category: COVID-19 | ||||||
| 01/27/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.43 | General |
| 10/13/2022 | Partner Therapeutics, Inc. | Leukine (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,356.88 | General |
| Category: Hematology/Oncology | ||||||
| 12/13/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $28.99 | General |
| 06/05/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 10/19/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $17.13 | General |
| 10/19/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $10.10 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 122 | 245 | $102,760 | $28,825 |
| 2022 | 3 | 62 | 186 | $65,345 | $17,998 |
| 2021 | 3 | 119 | 431 | $162,990 | $49,297 |
| 2020 | 5 | 134 | 427 | $137,790 | $39,686 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 78 | $42,900 | $12,102 | 28.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 47 | 109 | $38,150 | $11,603 | 30.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 32 | $20,800 | $4,901 | 23.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 16 | 26 | $910.00 | $218.40 | 24.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 133 | $45,330 | $12,171 | 26.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 36 | $19,420 | $5,778 | 29.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 12 | 17 | $595.00 | $50.04 | 8.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 66 | 332 | $109,560 | $31,795 | 29.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 56 | $25,480 | $9,489 | 37.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 36 | 43 | $27,950 | $8,013 | 28.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 58 | 236 | $77,880 | $22,592 | 29.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 28 | 135 | $31,050 | $8,990 | 29.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 24 | 26 | $16,900 | $4,889 | 28.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 11 | 17 | $7,735 | $2,074 | 26.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 13 | 13 | $4,225 | $1,141 | 27.0% |
About Dr. Catherine Small, MD
Dr. Catherine Small, MD is a Infectious Disease healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881617520.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Catherine Small, MD has received a total of $2,327 in payments from pharmaceutical and medical device companies, with $19.47 received in 2024. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1,357).
As a Medicare-enrolled provider, Small has provided services to 437 Medicare beneficiaries, totaling 1,289 services with total Medicare billing of $135,806. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Valhalla, NY
- Active Since 07/25/2006
- Last Updated 10/10/2014
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1881617520
Products in Payments
- Leukine (Drug) $1,357
- Veklury (Drug) $840.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Valhalla
Abhay Dhand, M.d, M.D
Infectious Disease — Payments: $276,400
Rajat Nog, M.d, M.D
Infectious Disease — Payments: $644.49
Mr. Zachary Fleischner, Md, MD
Infectious Disease — Payments: $232.48
Marc El Khoury, Md, MD
Infectious Disease — Payments: $192.98
Bettina Knoll
Infectious Disease — Payments: $102.44
Nahid Elbaggari
Infectious Disease